Xylazine (“Tranq”) in the Drug Supply: What Denver Metro Needs to Know

One of the most concerning emerging substances appearing in the illicit drug supply nationwide is xylazine, a veterinary sedative that is increasingly being found mixed with opioids like fentanyl. In some communities, it has become known on the street as “tranq” due to its strong sedating effects. While its presence in the Denver metro area is still relatively limited compared to some East Coast cities, public health officials are actively monitoring it as part of an evolving and increasingly dangerous drug supply.

Xylazine is not an opioid—it is actually a sedative used in veterinary medicine, primarily for large animals. However, when it enters the illicit drug market, it is often combined with fentanyl to prolong sedation and enhance effects. This combination is especially dangerous because xylazine does not respond to naloxone (Narcan), meaning that while Narcan may reverse the opioid component of an overdose, the sedative effects of xylazine can continue to suppress breathing and consciousness.

One of the most alarming impacts of xylazine use is the severe physical harm it can cause over time. Repeated exposure has been linked to deep skin wounds, infections, and poor healing, even in areas where injection did not occur. These injuries can become serious quickly and may require intensive medical treatment. Because it is often mixed into other drugs without the user’s knowledge, individuals may not realize they have been exposed until symptoms become severe.

In Colorado, including the Denver metro area, confirmed xylazine-related deaths remain relatively low but are being tracked closely by public health agencies. The concern is not just current prevalence, but the potential for rapid spread as drug supply chains shift and new adulterants move westward.

The rise of substances like xylazine highlights a broader reality: the modern street drug supply is increasingly unpredictable and contaminated. For individuals struggling with substance use, this unpredictability dramatically increases the risk of overdose and serious medical complications.

For families, churches, and community organizations in the Denver metro area, awareness is key. Understanding what xylazine is—and how it behaves differently from opioids—can help save lives and guide people toward appropriate treatment and intervention sooner.